Variant report
Variant | nsv982613 |
---|---|
Chromosome Location | chr9:11019439-11026009 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr9:11018319..11020122-chr9:11028284..11030426,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs562406370 | chr9:11021814-11021815 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs187669895 | chr9:11021837-11021838 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs10756163 | chr9:11021845-11021846 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs550538531 | chr9:11021846-11021847 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs567355775 | chr9:11021856-11021857 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs536308743 | chr9:11021923-11021924 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs548019185 | chr9:11021941-11021942 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs546213845 | chr9:11021954-11021955 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs191104744 | chr9:11021976-11021977 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs184024447 | chr9:11021999-11022000 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs370851200 | chr9:11022003-11022004 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs558017037 | chr9:11022013-11022014 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs577981232 | chr9:11022034-11022035 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs10959464 | chr9:11022051-11022052 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs115706121 | chr9:11022059-11022060 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs573588594 | chr9:11022086-11022087 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs142956713 | chr9:11022102-11022103 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs559416383 | chr9:11022109-11022110 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs188702051 | chr9:11022122-11022123 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs151095201 | chr9:11022139-11022140 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs10959465 | chr9:11022146-11022147 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs191661367 | chr9:11022151-11022152 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs185279681 | chr9:11022152-11022153 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs549561584 | chr9:11022162-11022163 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs567501833 | chr9:11022171-11022172 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs530128342 | chr9:11022182-11022183 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs113104833 | chr9:11022272-11022273 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs566940405 | chr9:11022288-11022289 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs182173526 | chr9:11022301-11022302 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs551597228 | chr9:11022314-11022315 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs571506211 | chr9:11022327-11022328 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs569330043 | chr9:11022335-11022336 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs187253958 | chr9:11022341-11022342 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs557316700 | chr9:11022343-11022344 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs1334022 | chr9:11022389-11022390 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs536230615 | chr9:11022417-11022418 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs566098331 | chr9:11022446-11022447 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs117365846 | chr9:11022447-11022448 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs572892317 | chr9:11022491-11022492 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs544745897 | chr9:11022498-11022499 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs565096900 | chr9:11022520-11022521 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs374395141 | chr9:11022565-11022566 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs544475435 | chr9:11022573-11022574 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs565663837 | chr9:11022577-11022578 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs10959466 | chr9:11022581-11022582 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs530360608 | chr9:11022582-11022583 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs189178061 | chr9:11022615-11022616 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs61250983 | chr9:11022636-11022637 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs13286992 | chr9:11022647-11022648 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs374761488 | chr9:11022652-11022653 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
abnormal development | 18461090 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma | 19074898 | CNVD |
Malignant melanoma | 19074898 | CNVD |
Prostate cancer | 16573809 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Cancer | 20164920 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 21764851 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioma | 17123091 | CNVD |
Lung cancer | 16773561 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Gastric cancer | 16891809 | CNVD |
Mental retardation | 17847001 | CNVD |
Cutaneous squamous cell carcinomas | 17420988 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21611746 | CNVD |
Melanoma | 22183965 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Autism | 20858261 | CNVD |
Epilepsy | 20858261 | CNVD |
Mental retardation | 20858261 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:11021800-11023000 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
2 | chr9:11023400-11023600 | Enhancers | Fetal Lung | lung |